Case report: Toxic epidermal necrolysis induced by tislelizumab in a patient with esophageal squamous cell carcinoma

Case report: Toxic epidermal necrolysis induced by tislelizumab in a patient with esophageal squamous cell carcinoma

BackgroundImmune checkpoint inhibitors (ICIs) have been widely applicated for the treatment of patients with advanced esophageal cancer. Skin-related adverse reactions are frequent with ICIs, with toxic epidermal necrolysis (TEN) being a severe and potentially life-threatening cutaneous reaction.Cas...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shilong Wu, Chenyang Xu, Huafeng Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-12-01
Series:	Frontiers in Medicine
Subjects:	toxic epidermal necrolysis tislelizumab esophageal squamous cell carcinoma immune-related adverse events skin toxicity
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2024.1522525/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Toxic epidermal necrolysis
by: Rosalie Mae M. Reyes, MD, et al.
Published: (2011-06-01)

Carbamazepine-Induced Toxic Epidermal Necrolysis
by: Kushal Gohel, et al.
Published: (2018-01-01)

Differential Diagnostics of Toxic Epidermal Necrolysis (Lyell’s Syndrome) in ICU: Case Reports
by: Yu. V. Molochkova, et al.
Published: (2022-01-01)

Utilization of Suprathel® in delayed surgical management of toxic epidermal necrolysis (TEN): A case report
by: Isabella Lipkin, et al.
Published: (2025-04-01)

Severe idiosyncratic drug reactions with epidermal necrolysis: A 5-year study
by: I O Fadeyibi, et al.
Published: (2011-01-01)

Severe idiosyncratic drug reactions with epidermal necrolysis: A 5-year study
by: I. O. Fadeyibi, et al.
Published: (2011-09-01)

Collagen sheet dressings for cutaneous lesions of toxic epidermal necrolysis
by: S. Bhattacharya, et al.
Published: (2011-09-01)

Collagen sheet dressings for cutaneous lesions of toxic epidermal necrolysis
by: S Bhattacharya, et al.
Published: (2011-01-01)

Fatal toxic epidermal necrolysis associated with an immune checkpoint inhibitor
by: Chiaki Seki, et al.
Published: (2025-05-01)

Palbociclib-induced Toxic Epidermal Necrolysis: A Case Report with Review of All Cases Secondary to Cyclin-dependent Kinase 4/6 Inhibitors
by: Aurore Devoldere, et al.
Published: (2025-01-01)

Clinical Profile and Treatment Outcome of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis at a Tertiary Hospital of Nepal
by: Anupa Khadka, et al.
Published: (2025-03-01)

Clinical Profile and Treatment Outcome of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis at a Tertiary Hospital of Nepal
by: Anupa Khadka, et al.
Published: (2025-03-01)

A review of the immunogenetics of Stevens-Johnson syndrome and toxic epidermal necrolysis
by: Ayca Kocaaga, et al.
Published: (2025-09-01)

Oral Cyclosporine Treatment for Four Pediatric Patients With Toxic Epidermal Necrolysis That Showed No Response to High-dose Corticosteroids in Combination With Intravenous Immunoglobulin: A Case Series
by: Peijing Li, MD, et al.
Published: (2025-01-01)

Wound management and dressing selection in Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review
by: Maiara C. Macagnan, et al.
Published: (2025-04-01)

Plasmapheresis for refractory toxic epidermal necrolysis unresponsive to conventional therapy: a case report and literature review
by: Shun-Qi Liao, et al.
Published: (2025-05-01)

Stevens-Johnson syndrome and toxic epidermal necrolysis in Saudi Arabia: a retrospective cross-sectional multicenter study
by: Rayan Alkhodair, et al.
Published: (2025-07-01)

Enfortumab Vedotin–Induced Toxic Epidermal Necrolysis in Metastatic Urothelial Carcinoma Complicated by Severe Gastrointestinal Bleeding
by: Aika Matsuyama, et al.
Published: (2025-07-01)

Lamotrigine, a Miscreant in Toxic Epidermal Necrolysis: A Rare Case Report
by: Mahima MAKHIJA, et al.
Published: (2023-03-01)

Flexible Nasendoscopy in Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis: A Ten-Year Otolaryngology Experience
by: Matthew Min Xian Yii, et al.
Published: (2025-03-01)

Recent developments in the research of Stevens-Johnson syndrome and toxic epidermal necrolysis: pathogenesis, diagnosis and treatment
by: Li-min Yao, et al.
Published: (2025-06-01)

Toxic epidermal necrolysis induced by moxifloxacin and exacerbated by clindamycin in an elderly patient: A case report
by: Yongguang Wang, et al.
Published: (2025-02-01)

Nursing care for a patient with intracerebral hemorrhage complicated with toxic epidermal necrolysis: a case report
by: Doudou Zhang, et al.
Published: (2025-07-01)

Toxic epidermal necrolysis as a variant of severe skin lesions in systemic lupus erythematosus
by: L. D. Vorobyeva, et al.
Published: (2019-01-01)

Recent advances in the diagnosis and treatment of Stevens–Johnson syndrome/toxic epidermal necrolysis
by: Yuko Watanabe, et al.
Published: (2025-07-01)

Co‐Trimoxazole‐Induced Toxic Epidermal Necrolysis: A Case Report From Nepal
by: Sandesh Gaire, et al.
Published: (2024-12-01)

Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN): an update
by: O. Mogole, et al.
Published: (2016-11-01)

Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: A 15-year Regional Burn Center Experience
by: Dima Obed, et al.
Published: (2025-06-01)

Epidemiological Characteristics and Prognostic Scoring in Toxic Epidermal Necrolysis and Stevens–Johnson Syndrome: Insights from a 17-Year Burn Center Experience
by: David Breidung, et al.
Published: (2025-01-01)

Staphylococcal scalded skin syndrome: A rare mimicker of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults
by: Omar Alani, ScB, et al.
Published: (2025-09-01)

Toxic epidermal necrolysis following lamotrigine replacement therapy in a woman planning pregnancy: a case report and literature review
by: Lili Zhang, et al.
Published: (2025-07-01)

Understanding the Gap Between Acute Complications and Long-Term Sequelae in Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Bandung, West Java, Indonesia: Experience from Two Institutions
by: Sutedja E, et al.
Published: (2025-04-01)

Systematic review, methodological appraisal, and recommendation mapping of clinical practice guidelines for managing patients with Stevens-Johnson syndrome and toxic epidermal necrolysis
by: Mohammed AlFada, et al.
Published: (2025-12-01)

Polymeric Micellar Paclitaxel Plus Cisplatin Combined With Tislelizumab as the First‐Line Treatment of Advanced Unresectable Esophageal Squamous Cell Carcinoma: A Phase II Study
by: Xiaoyou Li, et al.
Published: (2025-04-01)

Special immune-related adverse events and subsequent photodynamic therapy in tislelizumab treatment for esophageal cancer: a case report
by: Longzhao Li, et al.
Published: (2024-11-01)

Skin lesions and the role of the internist: a series of clinical cases
by: Carolina Bologna, et al.
Published: (2024-12-01)

Mortality in Dermatology: A Closer Look
by: Prachi Bhandare, et al.
Published: (2022-04-01)

Perioperative outcomes of neoadjuvant chemotherapy plus camrelizumab versus neoadjuvant chemotherapy plus tislelizumab for locally advanced esophageal squamous cell cancer: a real-world retrospective study
by: Qi Zhao, et al.
Published: (2025-08-01)

LYELL`S SYNDROME. PRACTICAL CASE
by: Z. A. Khokhlova, et al.
Published: (2018-06-01)

Risk of Stevens-Johnson Syndrome with AEDs
by: J Gordon Millichap
Published: (1995-12-01)